NASDAQ:CDLX Cardlytics (CDLX) Stock Price, News & Analysis $3.71 +0.16 (+4.51%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Cardlytics Stock (NASDAQ:CDLX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cardlytics alerts:Sign Up Key Stats Today's Range$3.44▼$3.7250-Day Range$3.38▼$5.2152-Week Range$2.89▼$20.52Volume981,965 shsAverage Volume1.18 million shsMarket Capitalization$188.55 millionP/E RatioN/ADividend YieldN/APrice Target$6.92Consensus RatingHold Company OverviewCardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.Read More… Cardlytics Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks64th Percentile Overall ScoreCDLX MarketRank™: Cardlytics scored higher than 64% of companies evaluated by MarketBeat, and ranked 128th out of 333 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingHold Consensus RatingCardlytics has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on no buy ratings, 5 hold ratings, and 1 sell rating.Amount of Analyst CoverageCardlytics has only been the subject of 3 research reports in the past 90 days.Read more about Cardlytics' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Cardlytics are expected to decrease in the coming year, from ($1.52) to ($1.70) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cardlytics is -0.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cardlytics is -0.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCardlytics has a P/B Ratio of 1.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.77% of the outstanding shares of Cardlytics have been sold short.Short Interest Ratio / Days to CoverCardlytics has a short interest ratio ("days to cover") of 9.3.Change versus previous monthShort interest in Cardlytics has recently decreased by 2.64%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCardlytics does not currently pay a dividend.Dividend GrowthCardlytics does not have a long track record of dividend growth. Sustainability and ESG2.8 / 5Environmental Score-0.67 Percentage of Shares Shorted13.77% of the outstanding shares of Cardlytics have been sold short.Short Interest Ratio / Days to CoverCardlytics has a short interest ratio ("days to cover") of 9.3.Change versus previous monthShort interest in Cardlytics has recently decreased by 2.64%, indicating that investor sentiment is improving. News and Social Media1.4 / 5News SentimentN/A News SentimentCardlytics has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.News Coverage This WeekMarketBeat has tracked 1 news article for Cardlytics this week, compared to 4 articles on an average week.MarketBeat FollowsOnly 1 people have added Cardlytics to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Cardlytics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $237,767.00 in company stock.Percentage Held by InsidersOnly 4.40% of the stock of Cardlytics is held by insiders.Percentage Held by Institutions68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Cardlytics' insider trading history. Receive CDLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter. Email Address CDLX Stock News HeadlinesCardlytics, Inc. (NASDAQ:CDLX) Receives $6.92 Consensus Target Price from BrokeragesDecember 16, 2024 | americanbankingnews.comNorthland Securities Keeps Their Hold Rating on Cardlytics (CDLX)December 11, 2024 | markets.businessinsider.comVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.December 22, 2024 | Porter & Company (Ad)Cardlytics Continues Revenue Contraction Amid Worsening EconomicsDecember 6, 2024 | seekingalpha.comWhy Is Cardlytics, Inc. (CDLX) Among The Best Advertising Stocks to Buy According to Hedge Funds?December 6, 2024 | msn.comCardlytics Faces Revenue Challenges and Uncertain Earnings Visibility Amid TransitionNovember 11, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Communication Services Companies: Zillow Group Class A (ZG), Take-Two (TTWO) and Cardlytics (CDLX)November 7, 2024 | markets.businessinsider.comCardlytics (NASDAQ:CDLX) Stock Quotes, Forecast and News SummaryNovember 7, 2024 | benzinga.comSee More Headlines CDLX Stock Analysis - Frequently Asked Questions How have CDLX shares performed this year? Cardlytics' stock was trading at $9.21 at the beginning of the year. Since then, CDLX shares have decreased by 59.7% and is now trading at $3.71. View the best growth stocks for 2024 here. How were Cardlytics' earnings last quarter? Cardlytics, Inc. (NASDAQ:CDLX) released its quarterly earnings data on Wednesday, November, 6th. The company reported ($0.15) EPS for the quarter, beating analysts' consensus estimates of ($0.33) by $0.18. The company's revenue was down 15.1% compared to the same quarter last year. Does Cardlytics have any subsidiaries? The following companies are subsidiaries of Cardlytics: Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited. When did Cardlytics IPO? Cardlytics (CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers. Who are Cardlytics' major shareholders? Top institutional shareholders of Cardlytics include Geode Capital Management LLC (2.07%), State Street Corp (1.72%), Baillie Gifford & Co. (1.14%) and RBF Capital LLC (0.96%). Insiders that own company stock include Clifford Sosin, Karim Saad Temsamani, Lynne Marie Laube, Scott D Grimes, Amit Gupta, Alexis Desieno, Nicholas Hollmeyer Lynton, Andrew Christiansen, John V Balen and Kirk Somers. View institutional ownership trends. How do I buy shares of Cardlytics? Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Cardlytics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Intel (INTC) and Rambus (RMBS). Company Calendar Last Earnings11/06/2024Today12/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Computer programming, data processing, & other computer related Sub-IndustryComputer Software Current SymbolNASDAQ:CDLX CUSIPN/A CIK1666071 Webwww.cardlytics.com Phone(888) 798-5802FaxN/AEmployees457Year Founded2008Price Target and Rating Average Stock Price Target$6.92 High Stock Price Target$12.00 Low Stock Price Target$3.50 Potential Upside/Downside+86.4%Consensus RatingHold Rating Score (0-4)2.14 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($6.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-134,700,000.00 Net Margins-93.55% Pretax Margin-93.55% Return on Equity-110.67% Return on Assets-32.70% Debt Debt-to-Equity Ratio2.40 Current Ratio1.18 Quick Ratio1.18 Sales & Book Value Annual Sales$293.47 million Price / Sales0.64 Cash Flow$1.19 per share Price / Cash Flow3.13 Book Value$3.43 per share Price / Book1.08Miscellaneous Outstanding Shares50,822,000Free Float48,586,000Market Cap$188.55 million OptionableOptionable Beta1.53 Social Links (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report This page (NASDAQ:CDLX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardlytics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardlytics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.